SU - NON-FINAL ACTION - MAILED
non
on 23 Nov 2024
Last Applicant/ Owned by
350 Oyster Point Blvd
South San Francisco
CA
94080
Serial Number
97979331 filed on 07th Mar 2022
Registration Number
N/A
Correspondent Address
B. Brett Heavner
B. Brett Heavner FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER LLP
WASHINGTON, DC 20001
United States
Filing Basis
1. intent to use
2. intent to use current
3. filed as use application
4. use application currently
Disclaimer
NO DATA
C.
research in the field of cellular assay screening and pharmaceutical discovery and development human pharmaceuticals for the treatment of cardiovascular diseases, diseases and conditions associated with cardiac muscle dysfunction, cardiac muscle wasting, cardiac muscle atrophy, cardiac muscle weakness
Classification Information
Class [042]
Computer & Software Services & Scientific Services
research in the field of cellular assay screening and pharmaceutical discovery and development
First Use Date in General
31st Aug 2015
First Use Date in Commerce
31st Aug 2015
Class [005]
Pharmaceutical Products
human pharmaceuticals for the treatment of cardiovascular diseases, diseases and conditions associated with cardiac muscle dysfunction, cardiac muscle wasting, cardiac muscle atrophy, cardiac muscle weakness
First Use Date in General
05th Jun 2023
First Use Date in Commerce
05th Jun 2023
Mark Details
Serial Number
No 97979331
Mark Type
No Service Mark
Attorney Docket Number
No 09367.0228
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.02 -
Plain single line circles
Legal History
| Status Date | Action Taken |
|---|---|
| 23rd Nov 2024 | SU - NON-FINAL ACTION - WRITTEN |
| 23rd Nov 2024 | NON-FINAL ACTION E-MAILED |
| 23rd Nov 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 22nd Nov 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 22nd Nov 2024 | DIVISIONAL PROCESSING COMPLETE |
| 24th Oct 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 20th Aug 2024 | USE AMENDMENT FILED |
| 20th Aug 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
| 20th Aug 2024 | SOU EXTENSION 3 FILED |
| 20th Aug 2024 | SOU EXTENSION 3 GRANTED |